KIRK - Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying | Benzinga
The Dow Jones closed higher by around 290 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Cadrenal Therapeutics
- The Trade: Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) Director John R. Murphy acquired a total of 20,000 shares an average price of $0.70. To acquire these shares, it cost around $13,973.
- What’s Happening: Cadrenal Therapeutics highlighted additional need for a new Vitamin K antagonist following updates from the recent European Society of Cardiology Congress.
- What ...